Literature DB >> 7514496

Coexpression of the c-kit receptor and the stem cell factor in gynecological tumors.

M Inoue1, S Kyo, M Fujita, T Enomoto, G Kondoh.   

Abstract

The protooncogene c-kit encodes a transmembrane receptor-type tyrosine kinase which belongs to the beta-PDGER/CSF-1 receptor tyrosine kinase family. The interaction between c-kit receptor and its corresponding ligand, stem cell factor (SCF), has been suggested to be involved in embryogenesis as well as carcinogenesis via the autocrine/paracrine system. In the present study, cancer cell lines and normal/benign/malignant tissues of the human female genital tract were examined for the expression of both c-kit and SCF by Northern blot and immunohistochemical analyses. Two of 16 cell lines showed mRNA expression of both c-kit and SCF, while 2 and 12 cell lines expressed c-kit and SCF, respectively. In tissues, several cases of malignant tumors, including three cervical cancers, one ovarian cancer, and one ovarian immature teratoma, expressed mRNA of both c-kit and SCF. In normal tissues, squamous epithelium expressed SCF immunohistochemically, while c-kit protein was detected only in melanocytes. Some tissues of malignant tumors, one squamous cell carcinoma of the cervix, two small cell carcinomas of the cervix, two serous adenocarcinomas of the ovary, and two immature teratomas of the ovary, expressed both c-kit and SCF proteins immunohistochemically. It is also notable that c-kit protein was expressed only in malignant germ cells of dysgerminomas, while SCF was expressed in the connective tissues surrounding germ cells. The present study suggests that the c-kit/SCF system may play an important role in the carcinogenesis of the female genital tract.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7514496

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  32 in total

Review 1.  Ocular mast cells. Characterization in normal and disease states.

Authors:  E B Cook; J L Stahl; N P Barney; F M Graziano
Journal:  Clin Rev Allergy Immunol       Date:  2001-04       Impact factor: 8.667

2.  A transforming mutation enhances the activity of the c-Kit soluble tyrosine kinase domain.

Authors:  L P Lam; R Y Chow; S A Berger
Journal:  Biochem J       Date:  1999-02-15       Impact factor: 3.857

3.  Blockade of NFκB activity by Sunitinib increases cell death in Bortezomib-treated endometrial carcinoma cells.

Authors:  Anabel Sorolla; Andrée Yeramian; Joan Valls; Xavier Dolcet; Laura Bergadà; Antoni Llombart-Cussac; Rosa Maria Martí; Xavier Matias-Guiu
Journal:  Mol Oncol       Date:  2012-07-07       Impact factor: 6.603

4.  Identification of cancer stem cell-like cells from human epithelial ovarian carcinoma cell line.

Authors:  M F Shi; J Jiao; W G Lu; F Ye; D Ma; Q G Dong; X Xie
Journal:  Cell Mol Life Sci       Date:  2010-06-12       Impact factor: 9.261

5.  Kaposi's sarcoma-associated herpesvirus-induced upregulation of the c-kit proto-oncogene, as identified by gene expression profiling, is essential for the transformation of endothelial cells.

Authors:  Ashlee V Moses; Michael A Jarvis; Camilo Raggo; Yolanda C Bell; Rebecca Ruhl; B G Mattias Luukkonen; Diana J Griffith; Cecily L Wait; Brian J Druker; Michael C Heinrich; Jay A Nelson; Klaus Früh
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

6.  The expression of KIT receptor dimers in gastrointestinal stromal tumors independent of c-kit mutation and SCF expression is associated with high-risk stratification.

Authors:  Cen Qiu; Xiaohong Liu; Chenguang Bai; DA Lie Ma
Journal:  Oncol Lett       Date:  2012-07-11       Impact factor: 2.967

7.  Androgen receptor increases CD133 expression and progenitor-like population that associate with cisplatin resistance in endometrial cancer cell line.

Authors:  Lumin Chen; Wei-Chun Chang; Yao-Ching Hung; Ying-Yi Chang; Bo-Yin Bao; Hsin-Ching Huang; Wei-Min Chung; Chih-Rong Shyr; Wen-Lung Ma
Journal:  Reprod Sci       Date:  2013-08-20       Impact factor: 3.060

8.  Aromatase excess in cancers of breast, endometrium and ovary.

Authors:  Serdar E Bulun; Dong Chen; Meiling Lu; Hong Zhao; Youhong Cheng; Masashi Demura; Bertan Yilmaz; Regina Martin; Hiroki Utsunomiya; Steven Thung; Emily Su; Erica Marsh; Amy Hakim; Ping Yin; Hiroshi Ishikawa; Sanober Amin; Gonca Imir; Bilgin Gurates; Erkut Attar; Scott Reierstad; Joy Innes; Zhihong Lin
Journal:  J Steroid Biochem Mol Biol       Date:  2007-05-24       Impact factor: 4.292

9.  Effect of c-kit ligand, stem cell factor, on mediator release by human intestinal mast cells isolated from patients with inflammatory bowel disease and controls.

Authors:  S C Bischoff; S Schwengberg; K Wordelmann; A Weimann; R Raab; M P Manns
Journal:  Gut       Date:  1996-01       Impact factor: 23.059

10.  Expression and mutational analysis of c-kit in ovarian surface epithelial tumors.

Authors:  Dong-Ja Kim; Myung-Hoon Lee; Tae-In Park; Han-Ik Bae
Journal:  J Korean Med Sci       Date:  2006-02       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.